Net Sales Margin: Myomo, Inc (MYO)

Official company branding of Myomo Inc. (MYO)

Stable capacity utilization at the exoprosthesis assembly plants is coupled with management's professionalism regarding Medicare insurance reimbursements. The net profit margin history demonstrates capital efficiency, while -33.10 represents a fresh level value. System reliability is ensured through the application of specialized medical logistics when transporting high-tech equipment to end users of Myomo, Inc. (MYO).

Myomo, Inc. (MYO) - Net Sales Margin from 07/04/2022 to 11/19/2026

Myomo, Inc (MYO) - metric breakdowns and financial figures

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Myomo, Inc.
Finished products of Myomo Inc.

Steady growth in profitability confirms the fundamental resilience of Myomo, Inc. (MYO) for long-term capital. This ratio measures the portion of net profit in every dollar of revenue, reflecting the overall efficiency of all business processes. By analyzing the current net profit margin, an investor can see the real return on operating activities relative to industry norms. The positive trend here is driven by the expansion of Medicare coverage for prosthetics, which allows the company to offset the costs of scaling its workforce.

Competitors of Myomo, Inc.

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Profit Rate NMTC|MODD - Net Margin|Net Margin Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Return on Sales by Net Profit|Net Return on Sales NVNO|Return on Sales by Net Profit SINT|Return on Sales by Net Profit Tenon Medical (TNON)|Net Margin ReWalk Robotics Ltd (LFWD)|Company Sales Margin Autonomix|Net Sales Margin IVF (invobioscience.com)|bonebiologics.com - Net Margin|AXNX - Net Margin|BIOL (BIOLASE) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin